More Cann Group Ltd. news
Cann Group Ltd.ASX: CAN

S3 Trial update

Jan 18, 2023 at 10:33 PM EST · Issued by Cann Group Ltd.

Filed with ASX · Jan 18, 2023 at 10:33 PM EST

On 6ix: 6ix.com/news/s3-trial-update

Cann Group Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cann Group Ltd. on 6ix

Story so far

  • Cann to begin recruitment for CBD phase 3 clinical trialFeb 15, 2022

Earlier from Cann

  • Appointment of new CEOJan 9, 2023
  • Cann Group and Haleon sign non-binding term sheetNov 6, 2022
  • Amended Quarterly Activities ReportOct 27, 2022
  • Share Purchase PlanOct 24, 2022
  • Chief Executive Officer role updateOct 23, 2022

Later from Cann

  • Cann Group half year resultsFeb 23, 2023
  • Investor presentationJun 14, 2023
  • Cann signs significant variation with key customerJun 20, 2023
  • Cann Group FY23 unaudited revenue resultsJul 4, 2023
  • July harvest confirms Cann on track to achieve 12.5T targetJul 23, 2023
All Cann news releases↗

Follow Cann into a list and get an email when it puts out news.

Follow Cann
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer